Welcome to Karolinska Institutet and Aprea
xxxxxxxxxxxxxxxxxxxxx		xxx

             Aprea AB develops target specific drugs for the treatment of cancer with non-functional p53

                  Postal address: Aprea AB, Karolinska Institutet Science Park, Nobels väg 3, SE-171 65 Solna, Sweden; Org. No.: 556631-2285